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Dendritic outgrowth and arborization are important for establishing neural circuit
formation. To date, little information exists about the involvement of the extracellular
matrix (ECM) and its cellular receptors in these processes. In our studies, we focus on
the role of dystroglycan (DG), a cell adhesion molecule that links ECM components to the
actin cytoskeleton, in dendritic development and branching. Using a lentiviral vector to
deliver short-hairpin RNA (shRNA) that specifically silences DG in cultured hippocampal
neurons, we found that DG knockdown exerted an inhibitory effect on dendritic tree
growth and arborization. The structural changes were associated with activation of
the guanosine triphosphatase Cdc42. The overexpression of DG promoted dendritic
length and branching. Furthermore, exposure of the cultures to autoactivating matrix
metalloproteinase-9 (aaMMP-9), a β-DG-cleaving protease, decreased the complexity
of dendritic arbors. This effect was abolished in neurons that overexpressed a β-DG
mutant that was defective in MMP-9-mediated cleavage. Altogether, our results indicate
that DG controls dendritic arborization in vitro in MMP-9-dependent manner.
Keywords: dystroglycan, dendritic arborization, extracellular matrix, MMP-9, Cdc42
Introduction
Dendritic structure and arborization have a profound impact on the processing of neuronal
information (Gulledge et al., 2005; Stuart et al., 2007). The molecular mechanisms that regulate
the formation of dendritic trees are precisely controlled. Aberrations in these mechanisms are the
basis of several neurodevelopmental disorders, including mental retardation and autism (Kulkarni
and Firestein, 2012). Appropriate dendritic branching is driven by numerous extracellular signals,
including neurotrophic factors, cell adhesion molecules, and neuronal activity, which lead to
changes in cytoskeletal organization (Jan and Jan, 2010; Arikkath, 2012). However, our current
understanding of how signal transduction from the extracellular matrix (ECM) controls neuronal
morphogenesis is still incomplete.
Dystroglycan (DG) is a cell adhesion receptor composed of α and β subunits that form
a link between the ECM and intracellular actin cytoskeleton. DG was identiﬁed as a glycan
component of the dystrophin glycoprotein complex (DGC) in skeletal muscles (Ervasti and
Campbell, 1991), but it is also expressed in the nervous system, epithelia, and endothelia (Durbeej
et al., 1998). Extracellular α-DG binds to numerous laminin G domain ligands, including laminins,
agrin, and perlecan (Gee et al., 1994; Talts et al., 1999), and presynaptic neurexins in the brain
(Sugita et al., 2001). The transmembrane β-DG anchors α-DG to the cell membrane via the
N-terminal domain and interacts with the cytoskeletal proteins dystrophin and utrophin via the
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C-terminal cytoplasmic domain (Ervasti and Campbell,
1991; Barresi and Campbell, 2006). Both subunits undergo
posttranslational modiﬁcations, such as proteolysis,
glycosylation, and phosphorylation (Moore and Winder, 2012).
Abnormalities in these processes underlie the pathogenesis of
several complex disorders, including dystroglycanopathies and
cancer (Singh et al., 2004; Moore and Hewitt, 2009).
Distinct functions of glial and neuronal DG in the brain
have been reported (Satz et al., 2010). These studies indicate
a crucial role for extracellular α-DG interactions, as the
cerebral cortex developed normally in transgenic mice that
lacked the DG intracellular domain. β-DG is also known
to interact directly with F-actin and thereby may inﬂuence
actin cytoskeleton remodeling, accompanied by morphological
changes (Chen et al., 2003). Moreover, β-DG has been identiﬁed
as a matrix metalloproteinase-9 (MMP-9) substrate that is
digested in response to enhanced neuronal activity (Michaluk
et al., 2007). The involvement of MMP-9 in neuronal plasticity
and the modulation of dendritic spine morphology has been
reported (Michaluk et al., 2011; Dziembowska and Wlodarczyk,
2012; Stawarski et al., 2014). However, the contribution of
MMP-9 and its substrates to dendritic morphogenesis is still
unclear. Notably, blockade of the proteolytic activity of MMP-
9, similarly as DG deletion in neurons, impairs hippocampal
long-term potentiation (LTP; Nagy et al., 2006; Satz et al.,
2010).
Although β-DG has been shown to be necessary for the
formation of ﬁlopodia and microvilli-like structures in numerous
cell types (Spence et al., 2004a; Batchelor et al., 2007), detailed
knowledge of the mechanisms of action of DG in neuronal
development is still lacking.
In the present study, we evaluated the eﬀects of the
knockdown or overexpression of DG on dendritic arborization
in hippocampal neurons in vitro. Our results showed that
DG deletion simpliﬁed dendritic arbor morphology and
decreased the total length of dendrites. Conversely, the
enhanced neuronal expression of DG resulted in a signiﬁcant
increase in dendritic length and branching. Moreover, we
found that treatment of the cultures with autoactivating
MMP-9 (aaMMP-9) decreased the complexity of dendritic
arbors, and this eﬀect was abolished in neurons that were
transfected with a plasmid carrying a β-DG with a mutation
in the MMP-9 cleavage site. Furthermore, the DG knockdown-
induced simpliﬁcation of dendritic arbor morphology was




All of the animal procedures were performed in accordance
with the guidelines of the First Local Ethical Committee on
Animal Research in Warsaw (permission no. 554/2013), based
on the Polish Act on Animal Welfare and other national
laws that are in full compliance with EU directives on animal
experimentation.
short-hairpin RNA (shRNA) Constructs and
Lentivirus Production
Two short-hairpin RNAs (shRNAs) for DG [SH1 DG
(GCUCAUUGCUGGAAUCAUUGC; described previously by
Jones et al., 2005) and SH2DG (UGUCGGCACCUCCAAUUU)]
were introduced to a pSilencer (with the U6 promoter) plasmid
(Ambion) as double-stranded oligonucleotides. The shRNAs
were then subcloned into the pTRIP-PL-WPRE vector together
with the SynGFP sequence, which enables the production
of lentiviruses that carry shRNA with the simultaneous
expression of green ﬂuorescent protein (GFP) driven by the
synapsin I promoter. As a control, we used a pTRIP-PL-WPRE
vector without shRNA. The lentiviruses were produced in the
Laboratory of Cell Engineering, Nencki Institute of Experimental
Biology.
Constructs for Dystroglycan Overexpression
The following expression plasmids were used: DG (α + β)
without any tag (OE DG), DG (α + β) fused with GFP
(OE DG-GFP), β-DG fused with GFP (OE β-DG-GFP), and
β-DG fused with GFP with a mutation in the MMP-9 cleavage
site (OE β-DG-MUT-GFP). The neurons were transfected with
the aforementioned vectors on the third day in vitro (DIV).
A red ﬂuorescent protein (RFP)-encoding vector was used
to visualize the morphology of transfected cells. All of the
overexpressed proteins were under the control of the synapsin I
promoter.
The DAG-1 coding sequence was ampliﬁed via RT-PCR
from total rat RNA using the following DG primers: forward
(GCATGTCTGTGGACAACTGGCTACTG) and reverse
(CGCGTCGACTTAAGGGGGTACATATGGAGG). The cDNA
of the full-length rat DAG1 gene, which encodes DG, was
cloned into pDrive vector (pDrive-DG). To generate OE DG,
DAG-1 cDNA was subcloned into a vector with the synapsin
I promoter (pSyn-GFP). The pSyn-GFP plasmid was cleaved
with HpaI and SalI enzymes, and the pDrive-DG plasmid
was cleaved with SalI and SnaBI enzymes. OE DG was used
to generate OE DG-GFP. We ampliﬁed GFP cDNA using
the following GFP primers that contained overhangs that
introduced NdeI and AseI restriction enzyme sites: forward
(CTGATCCATATGTACCCCCTATGGTGAGCAAGGGCGAG)
and reverse (GGCCGGATTAATTACTTGTACAGCTCGTCCA).
The OE DG plasmid was cleaved with NdeI and AseI enzymes.
We checked the obtained constructs for the proper orientation
of GFP.
OE DG-GFP was used to generate OE β-DG-GFP. We
deleted the cDNA region that encodes α-DG, leaving signaling
sequences and regions that encode β-DG using the following
primers: forward [TCTATTGTGGTCGAGTGGACCAACA
(DG-F-DEL)] and reverse [GGCTTGAGCCACAGCCACAGA
(DG-R-DEL)]. The mutation in the cleavage site (OE
β-DG-MUT-GFP) was generated by inserting two missense
point mutations using the following primers: forward
[GCACAGTTCATCCCGTGGCACCACCC (DG-MUT-F)]
and reverse [TGCTCGGCAACTGCCAGAGCCCGCCACAG
(DG-MUT-R)]. The missense mutation was generated by
changing His715 and Leu716 to alanines. The enzymes that
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were used for cloning were purchased from either New England
Biolabs or Thermo Scientiﬁc.
Hippocampal Neuronal Culture and
Transfection
Dissociated hippocampal cultures were prepared from postnatal
day 0 (P0) Wistar rats as described previously (Michaluk et al.,
2011). Cells were plated at a density of 120,000 cells per 18-mm-
diameter coverslips (Assistant, Germany) that were coated with
1 mg/ml poly-D-lysine (Sigma) and 2.5 μg/ml laminin (Roche).
The cells were kept at 37◦C in 5% CO2 in a humidiﬁed incubator
for 1 week. The cells were transfected with Eﬀectene (Qiagen)
or Lipofectamine 2000 Reagent (Invitrogen) according to the
manufacturer’s protocol on the indicated DIV with the given
plasmids. The experiments described below were performed on
8 DIV.
Cortical Neuronal Culture and Nucleofection
Dissociated cortical cultures were prepared from P0Wistar rats as
described previously (Michaluk et al., 2007). Following isolation,
4 × 106 cortical neurons per nucleofection were centrifuged for
5 min at 800 rcf. The pellet was gently resuspended in 100 μl
of nucleofection solution and mixed with 3 μg of the given
plasmids. The cell suspension was transferred to a nucleofector
cuvette and nucleofected using the O−03 program (Amaxa,
Lonza). Immediately after nucleofection, 1 ml of pre−warmed
complete growth medium was added to the cuvette. Cells were
transferred to six-well plates that contained 1 ml of medium. One
hour later, the medium was replaced with 2 ml of prewarmed
fresh complete growth medium. The cells were kept at 37◦C in
5% CO2 in a humidiﬁed incubator for 1 week. The experiments
were performed on 8 DIV.
For the Cdc42 activation assay, the cortical cell suspension was
plated on six-well plates that were covered with 1 mg/ml poly-
D-lysine (Sigma) and 2.5 μg/ml laminin (Roche) at a density of
1 × 106 cells per well.
Lentiviral Treatment of Neuronal Cultures
Primary hippocampal and cortical neurons were infected on 2
DIV with the described lentiviruses. For infection, 1,000 viral
particles per cell were used. To determine the silencing eﬀect
of the shRNA constructs, the speciﬁed amounts of the prepared
lentiviral vectors were added to the culture medium according to
previously tested ratios.
Cdc42 Activation Assay
On day 5 in vitro, 4 × 106 cortical neurons were homogenized
in lysis buﬀer [25 mM HEPES (pH 7.5), 150 mM NaCl, 1%
Non-idet P-40, 10 mMMgCl2, 1 mM ethylenediaminetetraacetic
acid (EDTA), and 2% glycerol] and centrifuged at 14,000 × g
for 10 min. The cell extracts were incubated with GST-PAK-
PBD (Cell BioLabs) fusion protein that had been conjugated
with glutathione beads at 4◦C overnight and washed three times
with lysis buﬀer. GST-PAK-PBD-bound Cdc42 was analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and subsequently immunoblotted with Cdc42-speciﬁc
antibody.
HEK 293 Culture and Transfection
Human embryonic kidney 293 (HEK 293) cells were grown
in Dulbecco’s modiﬁed Eagle medium (DMEM; Gibco) that
contained 10% fetal bovine serum (FBS; Invitrogen) and
100 U/ml penicillin/streptomycin (Gibco) at 37◦C in 5% CO2.
Transient transfection was performed using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Treatment with Recombinant MMP-9
The expression of the auto-activating mutant of MMP-9 G100L
(aaMMP-9) was evaluated as described previously (Michaluk
et al., 2007). Primary hippocampal cultures were treated with
100 ng/ml of aaMMP-9 every day beginning on 3 DIV.
To evaluate Cdc42 activity, primary cortical cultures were
treated with 400 ng/ml of aaMMP-9 on day 5 in vitro for 10 min.
To assess resistance to MMP-9 proteolytic activity, β-DG-MUT-
GFP-expressing HEK 293 cells were exposed to aaMMP-9 at a
concentration of 400 ng/ml for 3 h.
Inhibition of Cdc42 Activity
To block Cdc42 activity, the cultures were treated 3 DIV with
ZCL 278 (50 μM; Tocris), previously described as a selective
Cdc42 inhibitor (Friesland et al., 2013).
Western Blot
The cells were lysed in RIPA buﬀer (Sigma) that contained
150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium
deoxycholate, 0.1% SDS, and 50 mM Tris, pH 8.0. Protein
lysates were then separated by SDS-PAGE and transferred to
polyvinylidene diﬂuoride membranes (Immobilon-P, Millipore).
The membranes were then blocked with 10% non-fat milk in
Tris-buﬀered saline with 0.1% Tween 20 (TBST). After blocking,
the membranes were incubated overnight at 4◦C with primary
antibodies: anti-β-DG (1:500; ab49515, Abcam), horseradish
peroxidase (HRP)-GFP (1:1000; LS-C50850, LifeSpan
BioSciences), mouse anti-α-DG (1:1500; 05-593; Millipore),
and anti-β-actin (1:10000; A5441, Sigma) diluted in 5% non-fat
milk in TBST or anti-GFP (1:1000; MAB3580, Chemicon) and
anti-Cdc42 (1:500; 11A11, Cell Signaling) diluted in 5% bovine
serum albumin in TBST. The blots were washed three times with
TBST followed by 1 h incubation with peroxidase-conjugated
secondary antibody, diluted 1:5000 in TBST that contained 5%
non-fat milk. After washing, bands were detected using the ECL
PRIME chemiluminescence detection system (GE Healthcare).
Immunocytochemistry
For immunocytochemical studies cultured cells were ﬁxed 8
DIV with 4% paraformaldehyde (PFA) for 10 min at room
temperature and permeabilized with 0.1% Triton X-100 in
phosphate-buﬀered saline (PBST) for 10 min. After blocking
non-speciﬁc binding sites with 10% normal donkey serum (NDS)
diluted in PBST for 1 h at room temperature, the cells were
incubated with primary antibodies in PBST that contained 5%
NDS at 4◦C overnight. The following primary antibodies were
used: mouse anti-α-DG (1:100; 05-593, Millipore), mouse anti-
β-DG (1:50; ab49515, Abcam), rabbit anti-β-DG (1:100; sc-28535,
Santa Cruz Biotechnology), and mouse anti-MAP-2 (1:500;
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M4403, Sigma). After washing with PBS, secondary antibodies
conjugated with Alexa Fluor 647 or Alexa Fluor 555 (Molecular
Probes, Invitrogen) were applied for 1 h at room temperature.
After washing with PBS, the coverslips were mounted in anti-
quenching medium (Fluoromount G, Southern Biotechnology
Associates, Biozol, Eching, Germany) and subjected to imaging
analysis.
The speciﬁcity of used antibodies was previously conﬁrmed
by other studies (e.g., Michaluk et al., 2007; Pribiag et al., 2014).
Indeed, in our hands these antibodies have successfully veriﬁed
the eﬃciency of DG knockdown or DG overexpression.
Image Acquisition and Analysis
To study dendritic morphology, images of neurons were acquired
using a Leica TCS SP5 or SP8 confocal microscope with a PL Apo
40×/1.25 NA oil immersion objective. Morphometric analyses
were performed using ImageJ with NeuronJ software (Meijering
et al., 2004) and the Sholl plugin (Perycz et al., 2011). The axons
were excluded during marking tracings for Sholl analysis.
Statistical Analysis
The data are expressed as mean and SEM. Pair-wise datasets were
tested for signiﬁcant diﬀerences using Student’s t-test.
Results
Knockdown of Dystroglycan Simplifies
Dendritic Arbor Morphology
First we determined the time course of the expression of DG
in primary hippocampal cultures. We detected low level of
DG on 2 DIV, which was gradually increased up to 7 DIV
(Figure 1A). To deﬁne the possible role of DG in dendritic
tree arborization, we decreased its expression using lentiviral
shRNA vectors. To verify DG knockdown eﬃciency, the cells
were infected 2 DIV with shRNA1 (LV SH1 DG), shRNA2
(LV SH2 DG), or an empty lentivirus (LV GFP). After 6 days,
immunoﬂuorescence staining and Western blot were performed
(for detailed kinetic, see Supplementary Figure S1). As shown in
Figure 1B, neurons that were infected with LV SH1DG exhibited
a reduction of endogenous β-DG expression compared with LV
GFP-infected cells. Immunoblotting also revealed eﬃcient β-DG
down regulation caused by LV SH1 DG and LV SH2DG, whereas
high levels of β-DG expression were detected in cultures that
were infected with LV GFP and control non-infected cultures
(Figure 1C).
To evaluate the eﬀect of DG silencing on dendritic
morphogenesis, 4 days after infection the cultures were
additionally transfected with an RFP-encoding vector, which
allowed the observation of neuronal morphology. Images for
the morphometric analysis were acquired 8 DIV. We selected
this time point because intensive dendritogenesis in primary
hippocampal neurons occurs during the ﬁrst week in vitro.
Representative images of neurons in all of the groups are
presented in Figure 1D. Infection with LV SH1 DG and LV
SH2 DG clearly decreased the complexity of dendritic arbor
morphology compared with controls (non-infected cells or cells
infected with LV GFP). To precisely evaluate the pattern of
dendritic branching, we performed a Sholl analysis (Sholl, 1953),
which measures the number of dendrites that cross circles at
various radial distances from the cell soma. The results showed
that DG silencing induced the shrinkage of dendritic arbors
compared with controls, reﬂected by a downward shift of the
Sholl plot (Figure 1E). At most of the measured distances
(30–140 μm from the cell body), the number of crossings
was signiﬁcantly reduced in DG-deﬁcient neurons (p < 0.001).
Moreover, the shRNA-mediated knockdown of DG considerably
decreased the total dendritic length (Figure 1F; non-infected
cells: l = 1417 ± 38 μm, ncell = 109; LV GFP: l = 1367 ± 38 μm,
ncell = 85; LV SH1 DG: l = 759 ± 32 μm, ncell = 87; LV SH2
DG: l = 713 ± 32 μm, ncell = 51; p < 0.001). These results may
indicate that DG is an important regulator of dendritogenesis in
developing primary hippocampal neurons.
Overexpression of Dystroglycan Promotes
Dendritic Growth and Branching
To further conﬁrm the role of DG in dendritic morphogenesis, we
developed three plasmid vectors to overexpress DG in primary
neurons. The ﬁrst plasmid encoded DG that was fused with
GFP at the C-terminus (OE DG-GFP). However, to exclude
the possibility that the observed eﬀect was attributable to
disturbances in the C-terminal domain of DG, we also produced
a DNA construct without GFP (OE DG). Additionally, to
study the function of β-DG alone (without the α subunit) in
neuronal morphogenesis, we created a vector that overexpressed
β-DG (with a signaling sequence) fused with GFP (OE β-DG-
GFP).
To verify the eﬀectiveness of the aforementioned constructs,
we ﬁrst evaluated the expression of α- and β-DG by
immunoﬂuorescence and Western blot. In neurons that were
transfected with the OE DG, OE DG-GFP, or OE β-DG-GFP
vector, we observed enhanced β-DG immunostaining compared
with neighboring cells (Figure 2A). At the same time we noted
increased immunoreactivity of α-DG only in neurons transfected
with the OE DG or OE DG-GFP plasmid (Figure 2A). For
the Western blot analysis, we used nucleofection technology
(Amaxa, Lonza) to obtain high-eﬃciency transfection. The
immunoblotting of protein lysates with anti-β-DG and anti-
GFP antibodies revealed a band of approximately 70 kDa,
which corresponds to β-DG fused with GFP (Figure 2B). The
level of overexpression was lower than the endogenous levels
of β-DG, however by using synapsin promoter we obtained
increased expression of β-DG exclusively in neurons, while
endogenously it is also expressed in glial cells present in
hippocampal cultures. In addition, we observed increased level
of α-DG in HEK 293 cells transfected with OE DG-GFP vector
(see Supplementary Figure S2). These results conﬁrmed that we
were able to obtain DG overexpression in transfected cells, and
this DG overexpression was properly ascribed to the α and β
subunits.
To assess the eﬀect of DG overexpression on dendritic arbor
morphology, the cultures were transfected with the OE DG,
OE DG-GFP, or OE β-DG-GFP vector and co-transfected with
an RFP-coding vector 3 DIV. Images for the Sholl analysis
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FIGURE 1 | Knockdown of dystroglycan (DG) impairs dendritic tree
development. (A) Time-course of the DG expression in primary hippocampal
cultures – representative western blot analysis is shown. (B) Confocal images of
hippocampal neurons infected with either empty lentivirus [LV green fluorescent
protein (GFP)] or a lentivirus that carries short-hairpin RNA (shRNA) for DG (LV
SH1 DG) and immunostained with anti-β-DG antibody. (C) Western blot analysis
of β-DG expression in protein lysates from non-infected neurons (NI) and
neurons infected with LV GFP, LV SH1 DG, or LV SH2 DG. β-actin served as a
loading control. (D) Representative images of neurons used for the
morphometric analysis. The cells were transfected with an RFP-coding vector to
visualize the exact morphology. (E) Sholl analysis of hippocampal neurons
treated as indicated (NI, ncell = 109; LV GFP, ncell = 85; LV SH1 DG, ncell = 87;
LV SH2 DG, ncell = 51). At distances of 30–140 μm from the cell body, the
differences between DG-deficient neurons (LV SH1 DG and LV SH2 DG) and the
control groups (NI and LV GFP) were statistically significant (p < 0.001). (F) Total
dendritic length of neurons treated as in (C). Three independent experiments
were performed. The data are expressed as mean ± SEM. ∗∗∗p < 0.001
(Student’s t-test).
were acquired 8 DIV. As shown in Figure 2C, neurons that
overexpressed DG exhibited enhanced dendritic arborization,
regardless of the presence of the GFP tag in the construct. This
fact indicates that the presence of GFP likely did not interfere
with the C-terminal-mediated function of DG.
The morphometric analysis revealed an upward shift of
the Sholl plot in neurons that were transfected with the OE
DG, OE DG-GFP, or OE β-DG-GFP vector compared with
non-transfected cells (Figure 2D), indicating an increase in
the complexity of dendritic trees. At most of the measured
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FIGURE 2 | Overexpression of DG stimulates dendritic outgrowth
and arborization. (A) The upper panel shows confocal images of
hippocampal neurons transfected with a GFP-coding vector (GFP) or
vectors used for DG overexpression: OE DG (co-transfected with GFP),
OE DG-GFP, and OE β-DG-GFP (green). The lower panels show α-DG
(blue) and β-DG (red) immunofluorescence staining of cells in the same
fields. The arrowheads indicate transfected cells. (B) Immunoblot analysis
of GFP and β-DG expression in cortical neurons after nucleofection with
either OE DG-GFP or OE β-DG-GFP plasmid. Non-transfected cells (NT)
served as a control. (C) Representative images of neurons used for the
morphometric analysis. The cells were co-transfected with an
RFP-coding vector to visualize the exact morphology. (D) Sholl analysis
of hippocampal neurons treated as indicated (NT, ncell = 36; OE DG,
ncell = 40; OE DG-GFP, ncell = 57; OE β-DG-GFP, ncell = 56). At
distances of 80–120 μm from the cell body, the differences between
DG-overexpressed neurons (OE DG, OE DG-GFP, and OE β-DG-GFP)
and the control group (NT) were statistically significant (p < 0.001).
(E) Total dendritic length for neurons treated as in (C). Three
independent experiments were performed. The data are expressed as
mean ± SEM. ∗∗p < 0.01, ∗∗∗p < 0.001 (Student’s t-test).
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FIGURE 3 | Matrix metalloproteinase-9 (MMP-9) activity inhibits
dendritic growth and arborization. (A) Representative images of
hippocampal neurons from control culture and cultures treated with
autoactivating MMP-9 (aaMMP-9). The cells were transfected with an
RFP-coding vector to visualize the exact morphology. (B) Representative
images of hippocampal cultures treated as in (A) following immunofluorescence
staining with anti-MAP2 antibody. (C) Sholl analysis of hippocampal neurons
exposed to aaMMP-9 (ncell = 55) vs. control (ncell = 36) and neurons infected
with either LV SH1 DG (ncell = 87) or LV SH2 DG (ncell = 51). At distances of
20–130 μm from the cell body, the differences between aaMMP-9-treated
neurons and the control group were statistically significant (p < 0.001). At
distances of 10–90 μm from the cell body, no statistically significant differences
were found between aaMMP-9-treated neurons and neurons infected with LV
SH1 DG or LV SH2 DG. (D) Total dendritic length for neurons treated as in (C).
All of the experiments were performed in triplicate. The data are expressed as
mean ± SEM. ∗∗∗p < 0.001 (Student’s t-test).
distances (80–120 μm from the cell body), the number of
crossings signiﬁcantly increased in neurons that overexpressed
DG or β-DG (p < 0.001). The overexpression of DG
also aﬀected dendritic outgrowth (Figure 2E). The total
dendritic length increased in neurons that were transfected
with OE vectors compared with non-transfected cells (OE DG:
l = 2835 ± 114 μm, ncell = 40, p < 0.001; OE DG-GFP:
l = 2582 ± 92 μm, ncell = 57, p < 0.001; OE β-DG-GFP:
l = 2338 ± 97 μm, ncell = 56, p < 0.002; non-transfected cells:
l = 1856 ± 92 μm, ncell = 36).
The enhancing eﬀect on dendritic trees was observed only
in cells that were transfected 3 DIV. When transfection was
performed 5 DIV, these morphological changes were not
evident (data not shown). This observation indicates that DG
is particularly necessary during the early stages of dendritic
development. Interestingly, the overexpression of β-DG alone
(without α-DG) fused with GFP evoked a very similar eﬀect
on dendritic arbors as overexpressed full-length DG. These data
suggest an important role for β-DG in neuronal development.
MMP-9 Inhibits Dendritic Growth and
Branching
β-dystroglycan has been previously shown to be proteolytically
processed byMMP-9 in activated neurons (Michaluk et al., 2007).
Thus, we decided to examine the eﬀect of exogenous MMP-9 on
dendritic arborization. We treated primary hippocampal cultures
with recombinant aaMMP-9 once per day beginning 3 DIV.
As shown in Figure 3A, 5-day exposure to aaMMP-9 reduced
dendritic tree arborization compared with control untreated
neurons. Similarly, immunostaining against microtubule-
associated protein 2 (MAP2) showed decreased complexity of
the neural network in aaMMP-9-treated cultures (Figure 3B).
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FIGURE 4 | Matrix metalloproteinase-9 dependent cleavage of β-DG is
important for dendritic development. (A) Immunoblot analysis of β-DG and
GFP expression in protein lysates from HEK 293 cells transfected with either OE
β-DG-GFP (WT) or OE β-DG-MUT-GFP (MUT) plasmids and then treated with
aaMMP-9. β-actin served as a loading control. (B) Representative images of
neurons used for the morphometric analysis. The cells were co-transfected with
an RFP-coding vector to visualize the exact morphology. (C) Sholl analysis of
hippocampal neurons treated as indicated (ncell = 50 ± 4). In control cultures
(without aaMMP-9), no statistically significant differences were found between
DG-overexpressed neurons (transfected with either OE DG-GFP or OE
β-DG-GFP) and neurons transfected with the OE β-DG-MUT-GFP vector. In
cultures treated with aaMMP-9, at distances of 30–140 μm from the cell body,
the differences between DG-overexpressed neurons (OE DG-GFP and OE
β-DG-GFP) and neurons that overexpressed mutated β-DG (OE
β-DG-MUT-GFP) were statistically significant (p < 0.02). (D) Total dendritic
length for neurons treated as indicated. All of the experiments were performed in
triplicate. The data are expressed as mean ± SEM. ∗∗∗p < 0.001 (Student’s
t-test).
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FIGURE 5 | Cdc42 activity contributes to dendritic atrophy caused by
DG knockdown or MMP-9 treatment. (A) Western blot analysis of active
Cdc42 (Cdc42-GTP) and total Cdc42 in cortical neurons infected with LV
GFP, LV SH1 DG, or LV SH2 DG. Silencing efficiency was checked by
immunoblotting with anti-β-DG antibody. β-actin was used as a loading
control. (B) Western blot analysis of active Cdc42 (Cdc42-GTP) and total
Cdc42 in control and aaMMP-9-treated cortical neurons. Immunoblotting with
anti-β-DG served as a control for the proteolytic activity of MMP-9. β-actin
was used as the loading control. (C) Representative images of neurons used
for the morphometric analysis. The cells were transfected with an
RFP-coding vector to visualize the exact morphology. (D) Sholl analysis of
hippocampal neurons treated as indicated (LV GFP, ncell = 85; LV SH1 DG,
ncell = 87; LV GFP + Cdc42 inhibitor, ncell = 28; LV SH1 DG + Cdc42
inhibitor, ncell = 51). At distances of 20–140 μm from the cell body, the
differences between DG-deficient neurons that were treated with the Cdc42
inhibitor and DG-deficient neurons that were not treated with the Cdc42
inhibitor were statistically significant (p < 0.001). (E) Total dendritic length for
neurons treated as indicated. Three independent experiments were
performed. The data are expressed as mean ± SEM. ∗p < 0.05,
∗∗∗p < 0.001 (Student’s t-test).
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The morphometric analysis revealed that enhanced MMP-9
activity evoked the shrinkage of dendritic arbors compared with
untreated controls, reﬂected by a downward shift of the plot
(Figure 3C). At most of the measured distances (20–130 μm
from the cell body) the number of crossings was signiﬁcantly
reduced in aaMMP-9-treated neurons (p < 0.001). MMP-9
activity also decreased the total dendritic length (Figure 3C;
untreated cells: l = 1417 ± 38 μm, ncell = 109; aaMMP-9:
l = 829 ± 43 μm, ncell = 55; p < 0.001). Interestingly, the
morphology of aaMMP-9-treated neurons was very similar to
the morphology of DG-deﬁcient neurons. At distances of 10–
90 μm from the cell body, no statistically signiﬁcant diﬀerences
were found between aaMMP-9-treated neurons and neurons
that were infected with LV SH1 DG or LV SH2 DG. These
groups were also very comparable with regard to total dendritic
length, which was approximately 50% less than in controls
(Figure 3D). These results may indicate that MMP-9 is also
an important regulator of dendritogenesis and suggest that DG
and MMP-9 cooperate in regulating the morphology of dendritic
arbors.
MMP-9-Mediated Cleavage of β-DG is Involved
in Neuritogenesis
We found that the silencing of DG and enhanced activity
of MMP-9 exert similar eﬀects on dendritic morphology. To
test whether this similarity arises from the fact that MMP-
9 inactivates DG by proteolytic processing, we modiﬁed the
protease cleavage site in the OE β-DG-GFP vector using site-
directed mutagenesis. The OE β-DG-MUT-GFP vector was
introduced into HEK 293 cells, and its resistance to cleavage by
MMP-9 was determined. We performed Western blot using an
anti-GFP antibody to verify the cleavage of overexpressed β-DG
and anti-β-DG to verify the cleavage of endogenous β-DG. As
shown in Figure 4A, the mutation prevented the cleavage of
β-DG by MMP-9 compared with wild type β-DG.
We then attempted to determine whether chronic MMP-9
activity can prevent the enhancement of dendritogenesis that is
caused by DG overexpression. Neurons were transfected with OE
DG-GFP, OE β-DG-GFP, or OE β-DG-MUT-GFP and treated
once per day with aaMMP-9 beginning 3 DIV. As shown in
Figure 4B, aaMMP-9 treatment disrupted dendritogenesis in
neurons that overexpressed DG or β-DG but did not inﬂuence
the morphology of neurons that were transfected with OE β-DG-
MUT-GFP.
The results of the Sholl analysis showed that treatment
with aaMMP-9 induced the shrinkage of dendritic arbors
in neurons that were transfected with either OE DG-
GFP or OE β-DG-GFP, whereas we did not observe any
diﬀerences in neurons that were transfected with OE β-DG-
MUT-GFP after aaMMP-9 stimulation (Figure 4C). At
most of the measured distances (20–140 μm from the cell
body), the number of crossings in OE DG-GFP- or OE
β-DG-GFP-transfected neurons signiﬁcantly reduced upon
exposure to aaMMP-9 (p < 0.02 and 0.04, respectively). The
number of crossings in OE β-DG-MUT-GFP-transfected
neurons did not signiﬁcantly change after stimulation with
aaMMP-9.
We also evaluated the eﬀect of aaMMP-9 treatment on
total dendritic length. In neurons that overexpressed DG-GFP
or β-DG-GFP, daily stimulation with aaMMP decreased this
parameter (from l = 2582 ± 92 μm, ncell = 57 for OE
DG-GFP to l = 1856 ± 86 μm, ncell = 38 for OE DG-
GFP + aaMMP-9, p < 0.001; from l = 2338 ± 97 μm, ncell = 56
for OE β-DG-GFP to l = 1825 ± 75 μm, ncell = 50 for OE
β-DG-GFP + aaMMP-9, p < 0.001; Figure 4D). In contrast,
the total dendritic length was unchanged in OE β-DG-MUT-
GFP-transfected neurons upon aaMMP-9 stimulation (from
l = 2494 ± 102 μm, ncell = 46 for OE β-DG-MUT-GFP to
l= 2566± 90μm, ncell = 47 for OE β-DG-MUT-GFP+ aaMMP-
9, p = 0.39; Figure 4D).
We also compared the eﬀect of aaMMP-9 on OE β-DG-
GFP-transfected neurons with neurons that expressed OE
β-DG-MUT-GFP. We observed a signiﬁcantly lower number
of crossings (50–140 μm from the cell body, p < 0.002)
and a decrease in total dendritic length (p < 0.001) in
cells that were transfected with wild type β-DG-GFP. These
results indicate that the MMP-9-mediated cleavage of β-DG
is important for morphological changes that accompany
neuritogenesis.
Morphological Effects of DG Knockdown and
MMP-9 Treatment are Rescued by the
Inhibition of Cdc42 Activity
Cdc42 GTPase is well known to play an important role in
the growth and branching of axons and dendrites. DG has
been shown to cooperate with Cdc42 to induce the formation
of ﬁlopodia structures. Therefore, we examined whether DG
knockdown inﬂuences the activity of Cdc42 in cultured cortical
neurons using a pull-down assay with GST-PAK-PBD. We
observed an increase in the level of GTP-bound Cdc42 (i.e., active
Cdc42) in SH1 DG- and SH2 DG-infected neurons compared
with control untreated cells (Figure 5A). The enhanced activation
of Cdc42 GTPase was associated with a reduction of the
complexity of dendritic trees since the similar Cdc42 activation
was also observed in cultures that were exposed to aaMMP-9
(Figure 5B).
We next determined whether Cdc42 inhibition rescues
dendritogenesis in DG-deﬁcient neurons. LV SH1 DG-infected
hippocampal neurons were treated with 50 μM of the selective
Cdc42 inhibitor ZCL 278 (Friesland et al., 2013). As shown
in Figure 5C, the disruption of dendritogenesis was rescued
by blocking Cdc42 activity. Moreover, we did not observe
any signiﬁcant diﬀerences in dendritic arborization in LV
GFP-infected neurons evoked by treatment with the Cdc42
inhibitor.
The Sholl analysis revealed similar upregulation of dendritic
tree complexity in LV GFP-infected neurons, regardless of ZCL
278 treatment, and LV SH1 DG-infected cells that were exposed
to ZCL 278 compared with DG-deﬁcient neurons that were
only infected with LV SH1 DG. The number of crossings was
signiﬁcantly higher at most of the measured distances (20–
140 μm from the cell body; p< 0.001; Figure 5D).
Similarly, a high degree of rescue was observed with regard to
total dendritic length (from l = 759 ± 32 μm, ncell = 87 for SH1
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DG to l = 1531 ± 40 μm, ncell = 51 for SH1 DG + ZCL 278,
p< 0.001; Figure 5E). This parameter was only slightly increased
upon Cdc42 inhibition in LV GFP-infected cells.
These results suggest that DG plays a crucial role in the
process of neuritogenesis through the inhibition of Cdc42
activity. Furthermore, the enhancement of proteolytic MMP-9
activity may cause DG inactivation through cleavage, leading to
the disinhibition of Cdc42 and impairments in dendritic arbor
development.
Discussion
Dystroglycan is a major ECM receptor that is expressed in
various tissues, including the central nervous system (Durbeej
et al., 1998; Zaccaria et al., 2001). Deletion of the gene that
encodes DG (Dag1) causes early embryonic lethality in mice,
indicating its important role during mammalian development
(Williamson et al., 1997). Previous studies demonstrated that DG
expressed on glial cells is responsible for basement membrane
formation, whereas neuronal DG facilitates hippocampal LTP,
one of several phenomena that underlie synaptic plasticity
(Satz et al., 2010). The number and pattern of synapses
that are received by each neuron are well known to be
determined by dendritic outgrowth and arborization (Koleske,
2013). However, unknown is whether DG aﬀects dendritic
development, which is crucial in the formation of functional
neural networks.
The present study provides evidence that DG plays an
important role in early stages of neuritogenesis in cultured
hippocampal neurons. We detected a high level of DG expression
at 1 week in cultures. These results contradict previous research
published by Lévi et al. (2002) showing a very weak expression of
DG during maturation of hippocampal neurons in vitro. These
discrepancies may be due to diﬀerences in the models used
in both studies. We found that the lentiviral-mediated shRNA
knockdown of DG reduced dendritic growth and branching. In
contrast, the overexpression of either full-length DG or β-DG
alone had the opposite eﬀect (i.e., the promotion of dendritic
tree development). Furthermore, our results indicated that the
observed disturbances in dendritic arborization might be caused
by the MMP-9-mediated proteolysis of DG and are associated
with Cdc42 GTPase activation.
Neuron–ECM interactions are considered essential for proper
dendritic development and function (Myers et al., 2011; Skupien
et al., 2014; Thalhammer and Cingolani, 2014). DG is a high-
aﬃnity receptor for several ECM components, including laminin
(Ervasti and Campbell, 1991, 1993). The importance of the DG-
laminin interaction is supported by the fact that mice with
astrocyte-speciﬁc DG deletion exhibit discontinuities in pial
surface basal lamina (Moore et al., 2002). Since in the present
study we used cells grown on laminin, it would be interesting
to check whether the simpliﬁcation of dendritic arbors evoked
by DG silencing is attributable to the weakening of laminin
binding.
We further found that the overexpression of OE DG, OE
DG-GFP, or OE β-DG-GFP promoted hippocampal dendritic
development. Interestingly, the overexpression of β-DG caused
the same eﬀect on dendritic arborization as overexpression of
full-length DG that contained the α and β subunits. This may
indicate the important role of downstream signaling mediated by
β-DG. DG has been reported to be a scaﬀold protein that interacts
with components of the ERK-MAP kinase cascade (Spence et al.,
2004b; Moore and Winder, 2010). Moreover, the cytoplasmic
tail of β-DG has been shown to interact with utrophin, an
actin-binding protein, and directly with the actin cytoskeleton
(Chen et al., 2003).
We observed a pronounced eﬀect of DG on dendritic
maturation. We tested whether the MMP-9-mediated cleavage of
DG is functionally involved in this process. We found that daily
treatment of hippocampal cultures with aaMMP-9 for 5 days
inhibited dendritic growth and branching. Interestingly, this
eﬀect coincided with the eﬀect induced by infection with LV
SH DG. Given the results that indicated that MMP-9 interferes
with proper dendritic arbor formation, we next considered
how β-DG mutation in the MMP-9 cleavage site might aﬀect
dendritogenesis. We found that the overexpression of β-DG-
MUT-GFP abolished the growth-inhibiting eﬀect of MMP-9 on
dendritic trees. Matrix metalloproteinases were once believed to
regulate neurite extension by simply degrading the surrounding
ECM to create a passage for process outgrowth (Ethell and Ethell,
2007; Sarig-Nadir and Seliktar, 2010). However, more recent
in vitro and in vivo studies suggest that proteolytic cleavage
is directed toward speciﬁc ligands and receptors to regulate
neuronal development and regeneration (Fujioka et al., 2012). In
the present study, we found that MMP-9may act as a regulator of
dendritic arbor maturation, and the digestion of DG is important
for this activity.
Actin reorganization that accompanies morphological
changes is generally known to be regulated by Rho-family small
GTPases, such as Rho, Rac, and Cdc42. Their activity is strictly
controlled by multiple guanine nucleotide exchange factors
(GEFs), guanine nucleotide dissociation inhibitors (GDIs),
and GTPase-activating proteins (GAPs). DG was previously
shown to bind the cytoskeletal adapter protein ezrin and form a
complex with a Rho GEF that is responsible for activating Cdc42
and thus causing ﬁlopodia formation in ﬁbroblasts (Batchelor
et al., 2007). In the present study, we examined the expression
of active Cdc42 in LV SH DG-infected neurons and neurons
treated with aaMMP-9. In both cases, we observed an increase
in Cdc42 activity. This result was surprising because in most
studies published to date, Cdc42 inhibition resulted in signiﬁcant
simpliﬁcation of dendritic trees in many types of neuron (Govek
et al., 2005; Negishi and Katoh, 2005). However, the functional
outcome of the activity of GTPases must be considered within
the context of additional considerations, such as the temporal
control of activation and cell type. Notably, the signaling
pathways that employ Rho GTPases are highly regulated and
can produce diﬀerent cellular responses under diﬀerent cellular
conditions. For example, both constitutively active Cdc42 and
Rac1 that is expressed in Drosophila giant ﬁber neurons inhibit
neurite outgrowth (Allen et al., 2000). Moreover, our data
are consistent with the observation that the suppression of
Cdc42 signaling during mouse cortical development is required
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to promote the branching of dendritic trees (Rosário et al.,
2012). In the same paper, the authors showed that mutations
in Cdc42 GAP (NOMA-GAP) resulted in hyperactive Cdc42
and simpliﬁed dendritic branches. The complex role of
Cdc42 in dendritogenesis has recently been reviewed (Simó
and Cooper, 2012). One unresolved issue involves the DG-
dependent intracellular signaling pathways that regulate Cdc42
and cytoskeletal rearrangement.
Altogether, we established that DG is important for
dendritic outgrowth and arborization in primary hippocampal
neurons. Further studies are required to elucidate the signaling
mechanisms of DG action. However, our ﬁndings indicate the
involvement of MMP-9-mediated proteolytic cleavage of the
β-DG extracellular domain and intracellular activation of Cdc42
GTPase. These results may provide insights into the role of
interactions between cell adhesion receptors and the ECM in
neuritogenesis and synaptic plasticity and open the way to in vivo
studies that may help to understand the molecular bases of several
neurological disorders, including mental retardation associated
with dystroglycanopathies.
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